Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 199-202, February 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holmes, E. C.
Right arrow Articles by Morton, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holmes, E. C.
Right arrow Articles by Morton, D. L.

Delayed Cutaneous Hypersensitivity to Cell-free Tumor Antigens

E. Carmack Holmes1, Ralph A. Reisfeld and Donald L. Morton

Tumor Immunology Section of the Surgery Branch of the National Cancer Institute and The Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20014

The exposure of two different methylcholanthrene-induced strain 2 guinea pig sarcomas to low-intensity sonic energy provided cell-free extracts that could elicit tumor-specific delayed cutaneous hypersensitivity reactions. These extracts, when fractionated by diethylaminoethyl column chromatography, yielded a partially purified component capable of eliciting delayed cutaneous hypersensitivity reactions in tumor-immunized syngeneic guinea pigs, which reactions were highly specific for the tumor from which the extract was derived. These partially purified antigens, which were derived from tumors induced by the same chemical agent, could thus evoke, in tumor-immunized syngeneic guinea pigs, cellular immune responses that are specific for the immunizing tumor.

1 To whom reprint requests should be addressed, at Department of Surgery, The Johns Hopkins School of Medicine, Baltimore, Md. 21205.

Received 2/11/72. Accepted 10/18/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.